Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management

that they reduce death or disability. The committee were aware that short-course tranexamic acid is occasionally used in current practice if interventional treatment to secure the aneurysm is suitable but not available within a short time frame. However, the committee agreed that the administration of tranexamic acid should not delay interventional treatment to secure the aneurysm. How the recommendations might affect practice Nimodipine The recommendation is not expected to substantially change the current practice of giving nimodipine after an aneurysmal subarachnoid haemorrhage. Reducing the risk of venous thromboembolism The recommendation is not expected to change current practice. Return to recommendations Managing the culprit aneurysm Recommendations 1.2.4 to 1.2.8 Why the committee made the recommendations The committee noted that around half of people who survive an aneurysmal subarachnoid haemorrhage will have a second bleed from the culprit aneurysm within weeks, and the mortality from a second bleed can exceed 50%. Interventional treatment with endovascular coiling or neurosurgical clipping, if suitable, can secure the aneurysm and prevent rebleeding. The committee acknowledged that interventional treatment is not suitable for some people who have a major neurological deficit after an aneurysmal subarachnoid haemorrhage, and that the costs of long-term nursing care or rehabilitation can
